Dose adjustment based on a patient's renal function is a very current example of personalising therapy. While this kind of precision medicine holds great potential, it is often overlooked, particularly in younger patients. Darcie Streetman and Rachel Eyler explore the growing knowledge and tools available for optimising renal dosing.
14th January 2021
Improving standards of care nationwide with edge computing
6th January 2021
The year's legal decisions affecting the pharma industry
6th January 2021
Legal implications of sensitive data falling victim to a cyber-attack within the healthcare industry
6th January 2021
How tech-enabled patient autonomy can ease the healthcare burden
16th December 2020
The impending alterations to how pharma will engage with contractors may not be at the top of to do lists – but it should be, says Charlie Cox
16th December 2020
Siera Torontow considers pharma's success in dealing with ESG (Environmental, Social and Governance) issues and the impact on reputation
16th December 2020
A closer working relationship for pharma reps and healthcare professionals (HCPs)
16th December 2020
Partnerships to boost clinical research in rare diseases
16th December 2020
Is personalised direct to consumer healthcare a threat or an opportunity for the pharma establishment?
16th December 2020
A new wave of innovation is tackling antibiotic resistance
15th December 2020
How robots will help shape the look of the pharmaceutical industry in 2021
15th December 2020
How can pharma help drive COVID-19 vaccination adherence?
10th December 2020
Beyond serialisation – the use of on-dose authentication to protect patients and brands from the rising threat of counterfeit drugs
10th December 2020
The need to implement rigorous post-authorisation monitoring programmes as an added safety net for COVID-19 vaccines
1st December 2020
